Prostate gland as a target organ of thyroid hormones: advances and controversies.

Brenda Anguiano, Carlos Montes de Oca, Evangelina Delgado-González, Carmen Aceves
Author Information
  1. Brenda Anguiano: Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México. ORCID
  2. Carlos Montes de Oca: Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México.
  3. Evangelina Delgado-González: Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México.
  4. Carmen Aceves: Departamento de Neurobiología Celular y Molecular, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Campus Juriquilla, Querétaro, México.

Abstract

Thyroid hormones (THs) are involved in the development and function of the male reproductive system, but their effects on the prostate have been poorly studied. This work reviews studies related to the interrelationship between the thyroid and the prostate. The information presented here is based upon bibliographic searches in PubMed using the following search terms: prostate combined with thyroid hormone or triiodothyronine, thyroxine, hypothyroidism, hyperthyroidism, or deiodinase. We identified and searched 49 articles directly related to the issue, and discarded studies related to endocrine disruptors. The number of publications has grown in the last 20 years, considering that one of the first studies was published in 1965. This review provides information based on in vitro studies, murine models, and clinical protocols in patients with thyroid disorders. Studies indicate that THs regulate different aspects of growth, metabolism, and prostate pathology, whose global effect depends on total and/or free concentrations of THs in serum, local bioavailability, and the endocrine androgen/thyronine context.

Keywords

References

  1. Pathobiology. 2020;87(2):87-99 [PMID: 32045912]
  2. J Natl Cancer Inst. 2011 Nov 2;103(21):1572-87 [PMID: 22010182]
  3. Cancer Cell. 2007 Nov;12(5):419-31 [PMID: 17996646]
  4. Oncogene. 2011 Jul 28;30(30):3381-90 [PMID: 21399657]
  5. Prostate. 2008 May 1;68(6):610-9 [PMID: 18196550]
  6. PLoS One. 2012;7(10):e47730 [PMID: 23118893]
  7. Endocrinology. 2005 Jul;146(7):2864-71 [PMID: 15802494]
  8. Endocrinology. 1984 Oct;115(4):1283-8 [PMID: 6090097]
  9. Nat Rev Endocrinol. 2019 Aug;15(8):479-488 [PMID: 31160732]
  10. Andrologia. 2003 Jun;35(3):131-40 [PMID: 12780529]
  11. Clin Cancer Res. 2014 Dec 15;20(24):6559-69 [PMID: 25324143]
  12. Prostate. 2009 Jul 1;69(10):1109-18 [PMID: 19353593]
  13. J Endocrinol. 2006 Aug;190(2):363-71 [PMID: 16899569]
  14. Indian J Exp Biol. 1994 Sep;32(9):616-8 [PMID: 7814039]
  15. Urology. 1987 Feb;29(2):223-4 [PMID: 3811104]
  16. Int J Cancer. 2021 Feb 1;148(3):731-747 [PMID: 33034050]
  17. Am J Pathol. 2010 Apr;176(4):1891-900 [PMID: 20167864]
  18. Prostate. 2008 Jul 1;68(10):1133-42 [PMID: 18454446]
  19. Biol Reprod. 1997 Feb;56(2):475-82 [PMID: 9116149]
  20. Endocr Rev. 2020 Apr 1;41(2): [PMID: 31754699]
  21. Endocrinology. 1991 Jul;129(1):237-43 [PMID: 2055186]
  22. J Androl. 2005 May-Jun;26(3):422-8 [PMID: 15867011]
  23. Physiol Rev. 2021 Jan 1;101(1):319-352 [PMID: 32584192]
  24. Mol Endocrinol. 1990 Sep;4(9):1343-53 [PMID: 2172800]
  25. World J Mens Health. 2019 Sep;37(3):257-260 [PMID: 31190488]
  26. Cold Spring Harb Perspect Med. 2019 Feb 1;9(2): [PMID: 29844220]
  27. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):570-4 [PMID: 19155436]
  28. Medicine (Baltimore). 2018 Sep;97(39):e12459 [PMID: 30278528]
  29. Front Endocrinol (Lausanne). 2021 Jun 21;12:691736 [PMID: 34234745]
  30. Am J Med Sci. 2000 Feb;319(2):96-9 [PMID: 10698093]
  31. J Endocrinol. 1971 Apr;49(4):591-8 [PMID: 5090070]
  32. J Steroid Biochem Mol Biol. 2020 Jul;201:105689 [PMID: 32360904]
  33. CA Cancer J Clin. 2021 May;71(3):209-249 [PMID: 33538338]
  34. Mol Cell Endocrinol. 1995 Mar;109(1):105-11 [PMID: 7540569]
  35. Int J Androl. 2000 Jun;23(3):156-62 [PMID: 10844541]
  36. Eur J Endocrinol. 2017 Oct;177(4):297-308 [PMID: 28684452]
  37. J Endocrinol. 2020 Dec;247(3):225-238 [PMID: 33112811]
  38. Urology. 2006 Dec;68(6):1198-205 [PMID: 17169643]
  39. Biol Reprod. 2011 Jan;84(1):118-23 [PMID: 20811014]
  40. Mol Cell Endocrinol. 2016 Dec 5;437:252-260 [PMID: 27492966]
  41. BMC Endocr Disord. 2020 Jun 9;20(1):83 [PMID: 32517676]
  42. Gen Comp Endocrinol. 2013 Oct 1;192:2-14 [PMID: 23524004]
  43. Br J Biomed Sci. 2016;73(2):94-6 [PMID: 27181171]
  44. Endocr Rev. 2019 Aug 1;40(4):1000-1047 [PMID: 31033998]
  45. J Endocrinol. 1987 Aug;114(2):271-7 [PMID: 3116140]
  46. Gerontology. 2019;65(5):458-464 [PMID: 30943489]
  47. Mol Cancer Res. 2019 Nov;17(11):2154-2168 [PMID: 31395667]
  48. PLoS One. 2021 Jan 22;16(1):e0244985 [PMID: 33481853]
  49. Oncogene. 2019 May;38(22):4412-4424 [PMID: 30742096]
  50. Mol Endocrinol. 1989 Feb;3(2):392-9 [PMID: 2710139]
  51. Eur J Endocrinol. 2021 Mar;184(3):477-486 [PMID: 33444229]
  52. J Urol. 2002 Dec;168(6):2431-3 [PMID: 12441933]
  53. Prostate. 2003 May 15;55(3):219-37 [PMID: 12692788]
  54. Prostate Cancer Prostatic Dis. 2001;4(4):232-234 [PMID: 12497024]
  55. Mol Cell Endocrinol. 2009 Oct 15;309(1-2):82-92 [PMID: 19540305]
  56. Endocr Relat Cancer. 2020 Apr;27(4):245-259 [PMID: 32045361]
  57. Int J Androl. 1998 Jun;21(3):121-8 [PMID: 9669196]
  58. Indian J Exp Biol. 1993 May;31(5):414-6 [PMID: 8395467]
  59. Thyroid. 2008 Feb;18(2):157-65 [PMID: 18279016]
  60. J Mol Endocrinol. 1992 Feb;8(1):63-72 [PMID: 1543535]
  61. Anticancer Res. 2020 Apr;40(4):2323-2329 [PMID: 32234933]
  62. Prostate. 2010 May 15;70(7):689-700 [PMID: 20033886]
  63. Proc Soc Exp Biol Med. 1962 Nov;111:290-2 [PMID: 13984755]
  64. Endocrinology. 1985 Sep;117(3):1201-8 [PMID: 4017962]
  65. Exp Cell Res. 2016 Oct 1;347(2):350-9 [PMID: 27569004]
  66. Onco Targets Ther. 2020 Jul 28;13:7411-7422 [PMID: 32801764]
  67. J Androl. 2001 Jan-Feb;22(1):136-41 [PMID: 11191079]
  68. Endocr Res. 2002 Aug;28(3):141-54 [PMID: 12489564]
  69. Prostate. 2009 Nov 1;69(15):1651-9 [PMID: 19644939]
  70. Endocrinology. 1999 Apr;140(4):1665-71 [PMID: 10098501]
  71. Chin J Physiol. 1999 Jun 30;42(2):89-94 [PMID: 10513604]
  72. Endocrinology. 2007 Jul;148(7):3485-95 [PMID: 17412801]
  73. Mol Med. 2016 Sep;22:1-11 [PMID: 26928389]
  74. Gene. 1995 Oct 3;163(2):331-2 [PMID: 7590294]
  75. World J Mens Health. 2019 Sep;37(3):364-371 [PMID: 30644234]
  76. Int J Androl. 2011 Apr;34(2):124-37 [PMID: 20546049]

Word Cloud

Created with Highcharts 10.0.0prostatethyroidstudiesTHsrelatedhormonesinformationbasedendocrineThyroidinvolveddevelopmentfunctionmalereproductivesystemeffectspoorlystudiedworkreviewsinterrelationshippresenteduponbibliographicsearchesPubMedusingfollowingsearchterms:combinedhormonetriiodothyroninethyroxinehypothyroidismhyperthyroidismdeiodinaseidentifiedsearched49articlesdirectlyissuediscardeddisruptorsnumberpublicationsgrownlast20yearsconsideringonefirstpublished1965reviewprovidesvitromurinemodelsclinicalprotocolspatientsdisordersStudiesindicateregulatedifferentaspectsgrowthmetabolismpathologywhoseglobaleffectdependstotaland/orfreeconcentrationsserumlocalbioavailabilityandrogen/thyroninecontextProstateglandtargetorganhormones:advancescontroversiesandrogenscancerhyperplasia

Similar Articles

Cited By